Henderson DC - Search Results

1

"Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".

Jackson JW, Fulchino L, Rogers J, Mogun H, Polinski J, Henderson DC, Schneeweiss S, Fischer MA. Jackson JW, et al. Among authors: henderson dc. Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):95-104. doi: 10.1002/pds.4354. Epub 2017 Nov 23. Pharmacoepidemiol Drug Saf. 2018. PMID: 29168261

2

Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder.

Vincenzi B, Greene CM, Ulloa M, Parnarouskis L, Jackson JW, Henderson DC. Vincenzi B, et al. Among authors: henderson dc. J Psychiatr Pract. 2016 May;22(3):175-82. doi: 10.1097/PRA.0000000000000149. J Psychiatr Pract. 2016. PMID: 27123797 Free PMC article.

3

Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Henderson DC. Henderson DC. CNS Drugs. 2002;16(2):77-89. doi: 10.2165/00023210-200216020-00001. CNS Drugs. 2002. PMID: 11825099 Review.

4

Schizophrenia and diabetes.

Henderson DC, Ettinger ER. Henderson DC, et al. Int Rev Neurobiol. 2002;51:481-501. doi: 10.1016/s0074-7742(02)51014-x. Int Rev Neurobiol. 2002. PMID: 12420368 Review. No abstract available.

5

Clozapine and hypertension: a chart review of 82 patients.

Henderson DC, Daley TB, Kunkel L, Rodrigues-Scott M, Koul P, Hayden D. Henderson DC, et al. J Clin Psychiatry. 2004 May;65(5):686-9. doi: 10.4088/jcp.v65n0514. J Clin Psychiatry. 2004. PMID: 15163256

6

A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.

Goff DC, Herz L, Posever T, Shih V, Tsai G, Henderson DC, Freudenreich O, Evins AE, Yovel I, Zhang H, Schoenfeld D. Goff DC, et al. Among authors: henderson dc. Psychopharmacology (Berl). 2005 Apr;179(1):144-50. doi: 10.1007/s00213-004-2032-2. Epub 2004 Oct 21. Psychopharmacology (Berl). 2005. PMID: 15502972 Clinical Trial.

7

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins AE, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC. Henderson DC, et al. Arch Gen Psychiatry. 2005 Jan;62(1):19-28. doi: 10.1001/archpsyc.62.1.19. Arch Gen Psychiatry. 2005. PMID: 15630069

8

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.

Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA. Evins AE, et al. Among authors: henderson dc. J Clin Psychopharmacol. 2005 Jun;25(3):218-25. doi: 10.1097/01.jcp.0000162802.54076.18. J Clin Psychopharmacol. 2005. PMID: 15876899 Clinical Trial.

9

Schizophrenia and comorbid metabolic disorders.

Henderson DC. Henderson DC. J Clin Psychiatry. 2005;66 Suppl 6:11-20. J Clin Psychiatry. 2005. PMID: 16107179 Review.

10

Dietary intake profile of patients with schizophrenia.

Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, Louie P, Cather C, Eden Evins A, Freudenreich O, Taber SM, Goff DC. Henderson DC, et al. Ann Clin Psychiatry. 2006 Apr-Jun;18(2):99-105. doi: 10.1080/10401230600614538. Ann Clin Psychiatry. 2006. PMID: 16754415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272 results

Search Page